PubMed期刊
期刊
会议
图书
作者:Wang Zhao , Zhang Qiang , Sun Yungang ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.131-142
摘要:Background(#br)Non-small cell lung cancer (NSCLC) is a common malignancy over the world. Previous report indicated that the plasmacytoma variant translocation 1 (PVT1) has been documented to function as an oncogene in various types of human cancers. However, the biological mechan...
作者:Leow Jeffrey J , Liu Zhenbang , Tan Teck Wei ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.1-15
摘要:Introduction(#br)Upper tract urothelial carcinoma (UTUC) is a relatively uncommon urologic malignancy for which there has not been significant improvement in survival over the past few decades, highlighting the need for optimal multi-modality management.(#br)Methods(#br)A non-sys...
作者:Saleem Muhammad Zubair , Nisar Muhammad Azhar , Alshwmi Mohammed ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.435-450
摘要:Purpose(#br)Breast cancer is the most common malignancy among women across the globe. Despite concerted efforts to improve the prevailing treatment modalities, the overall prognosis of breast cancer remains unsatisfactory. Recently, antiproliferative activity of Brevilin A (Brv-A...
作者:Yu Zhuojun , Yu Huichuan , Zou Qi ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.309-321
摘要:Background(#br)Colorectal cancer (CRC) patients with different molecular phenotypes, including microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and somatic mutations in BRAF and KRAS gene, vary in treatment response and prognosis. However, molecular pheno...
作者:Zhang Xiangyu , Huang Jingwen , Yu Chao ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.513-523
摘要:Introduction(#br)Prostate cancer is one of the most common cancers threatening public health worldwide. Although chemotherapy plays an important role in treating prostate cancer, it leads to many adverse effects and is prone to drug resistance. Quercetin, a natural product, is us...
作者:Su Xueliang , Wang Bangjie , Wang Yehong ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.277-289
摘要:Background(#br)Colorectal cancer is a leading cause of cancer-related death in the world. Despite cisplatin is a commonly used chemotherapeutic drug for the colorectal cancer treatment, resistance of cancer cells to cisplatin restricts its clinical efficacy. It is important to ex...
作者:Ding Jun , Zhang Lin , Chen Shiwen ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.1431-1445
摘要:Background(#br)Aggressive metastasis of tumor cells assumed a constructive role in strengthening chemoresistance of tumors, so this investigation was intended to elucidate if lncRNA CCAT2 sponging downstream miR-424 regulated chemotolerance of glioma cells by boosting metastasis ...
作者:Luo Fei , Zhou Zunyan , Cai Jun ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.1447-1460
摘要:Background(#br)Here, we probed the action mechanism of ubiquitin-specific processing proteases 17 (DUB3) in the evolution of oral squamous cell carcinoma (OSCC).(#br)Methods(#br)The expression of genes were calculated by qRT-PCR, and proteins were assessed by Western blot and imm...
作者:Chen Yihong , Deng Ganlu , Fu Yaojie ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.1625-1635
摘要:Background(#br)Chemoresistance is a major obstacle to improving the survival rate of colorectal cancer (CRC) patients. Forkhead box protein C2 (FOXC2), a member of the forkhead box (Fox) transcription factor family, is reported to be an important regulator of epithelial-to-mesenc...
作者:Wang Si-Si , Ye Dao-Xiong , Wang Bo ...
来源:[J].OncoTargets and therapy(IF 2.073), 2020, Vol.13, pp.585-591
摘要:Purpose(#br)Primary squamous cell carcinoma is a rare malignancy in the thyroid gland (SCCTh). The overall prognosis of this carcinoma is poor. This study aimed to explore the application of Raman spectroscopy in investigating the expression of CK5/6 and P63 in SCCTh.(#br)Patient...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×